This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Joseph Negri: Innovator in Cancer Treatment
Introduction
Joseph Negri is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative approach focuses on the use of reversine and its analogs to combat cancer effectively.
Latest Patents
Joseph Negri holds 1 patent for his work titled "Use of reversine and analogs for treatment of cancer." This patent outlines methods and compositions for treating cancer. In one embodiment, the method involves administering an effective amount of reversine, reversine analog, or a reversine-containing agent to a patient suffering from cancer. Additionally, the patent describes compositions that may include reversine along with other active agents and additives, showcasing its potential utility in medical applications.
Career Highlights
Negri is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research and innovations in cancer treatment. His work is pivotal in developing new therapeutic strategies that could improve patient outcomes.
Collaborations
Joseph Negri has collaborated with esteemed colleagues such as Constantine S Mitsiades and Nicholas Mitsiades. These partnerships enhance the research efforts and broaden the impact of their work in the medical community.
Conclusion
Joseph Negri's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to make a significant difference in the lives of patients battling cancer.